Report for: Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial

Title	Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial
Published in	Trials, September 2021
DOI	10.1186/s13063-021-05367-6
Pubmed ID	34479601
Authors	Eleonora Aricò, Luciano Castiello, Laura Bracci, Francesca Urbani, Flavia Lombardo, Ilaria Bacigalupo, Antonio Ancidoni, Nicola Vanacore, Alessandro Falcione, Chiara Reggiani, Giovanni Marco Dutti, Maria Grazia Maglie, Ombretta Papa, Pier Luigi Bartoletti, Giuseppina Ozzella, Nazario Bevilacqua, Emanuele Nicastri, Filippo Belardelli, Giuseppe Sconocchia

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.

Country	Count	As %
United States	1	25%
Unknown	3	75%

Type	Count	As %
Members of the public	2	50%
Scientists	1	25%
Science communicators (journalists, bloggers, editors)	1	25%

Mendeley readers

The data shown below were compiled from readership statistics for 216 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Country	Count	As %
Unknown	216	100%

Readers by professional status	Count	As %
Student > Master	23	11%
Student > Bachelor	18	8%
Student > Ph. D. Student	17	8%
Researcher	12	6%
Librarian	10	5%
Other	31	14%
Unknown	105	49%

Readers by discipline	Count	As %
Medicine and Dentistry	40	19%
Nursing and Health Professions	19	9%
Social Sciences	7	3%
Unspecified	7	3%
Psychology	5	2%
Other	24	11%
Unknown	114	53%

Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial